BI 706321 / Boehringer Ingelheim  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BI 706321 / Boehringer Ingelheim
NCT04241458: A Study to Test How Well Healthy Men and Women Tolerate Different Doses of BI 706321

Completed
1
39
Europe
BI 703621, Placebo, Midazolam
Boehringer Ingelheim
Healthy Volunteers
11/20
11/20
NCT03971695: A Study to Test How Well Healthy Men Tolerate Different Doses of BI 706321

Completed
1
61
Europe
BI 706321, Placebo
Boehringer Ingelheim
Healthy
12/20
12/20
NCT04714073: A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood

Completed
1
14
Europe
BI 706321, Itraconazole
Boehringer Ingelheim
Healthy
04/21
04/21
NCT05183360: A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated

Recruiting
1
60
Japan
BI 706321, Placebo
Boehringer Ingelheim
Healthy
10/25
10/25

Download Options